Company News
02/11/2022
Vibrent Health Rebrands its Health Research Participant Portal as “Participant Cloud” to Reflect Virtual Research Capabilities, Accessibility and Flexibility
Vibrent Health enhances and rebrands its consumer-facing digital health platform for data collection, recruitment and engagement of health research participants Fairfax, VA., – Vibrent Health, a digital health technology startup dedicated to powering the future of precision health research, announced a rebranding of their participant-facing digital health research portal and mobile apps, formerly the …
01/31/2022
UVA teaming up with Charlottesville pharmaceutical company for new burn treatment
CHARLOTTESVILLE, Va. (WVIR) – The University of Virginia School of Medicine is teaming up with a Charlottesville company to create a new burn treatment. Typically when skin is burned, the area surrounding it is impacted and dead, too. This new treatment is a cream that is put directly on severe wounds. “Our hope is that …
01/25/2022
GMU/ICAP Mentorship Program Connects Mentors with Growing Life Science Startups
Baltimore, MD, (BioBuzz) – Developing an ecosystem for life sciences startups takes a lot of energy and support. The Innovation Commercialization Assistance Program (ICAP), a program of George Mason University and the Virginia SBDC, has been laying the groundwork to support these emerging companies and has tapped two new life sciences mentors to provide guidance …
01/24/2022
ADIAL PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE ON U.S. PATENT FOR THE TREATMENT FOR OPIOID USE DISORDER USING AD04
CHARLOTTESVILLE, Va., (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the U.S. Patent and Trademark Office (USPTO) has mailed a Notice of Allowance for US Patent Application No. 16/784,051, a patent application for the treatment for opioid …
01/20/2022
New Report Outlines Best Practices in Bioscience Economic Development Initiatives
The Biotechnology Innovation Organization (BIO), in partnership with the Council of State Bioscience Associations (CSBA), released a new report on bioscience economic development best practices, “Driving the Bioscience Economy Forward During the COVID-19 Pandemic: Best Practices in State and Regional Economic Development Initiatives.” Now in its sixth edition, the report serves as a leading analysis …
01/14/2022
Cadence Adds New Class 7 (10,000) Cleanroom in Connecticut
Cadence, Inc., a leading contract manufacturer of medical devices, announced today the completion of a certified International Organization for Standardization (ISO) Class 7 (10,000) cleanroom at its Connecticut manufacturing facility. The new cleanroom is dedicated to the production of innovative medical device components and subassemblies. “The cleanroom opens the door to new, exciting opportunities for …
01/13/2022
Vibrent Health Integrates Electronic Health Records into its Digital Research Platform, Empowering Participants to Share Their Data for Clinical Research
New framework based on HL7 Fast Healthcare Interoperability Resources (FHIR) gives Standards based access to EHR data to accelerate clinical research and digital trials FAIRFAX, Va. — Vibrent Health, a health technology startup powering the future of precision health research, announced the integration of electronic health record (EHR) data into its Digital Health Solutions Platform, a …
01/11/2022
Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research
ROCKVILLE, Md.–(BUSINESS WIRE)– Hibiscus BioVentures, a firm committed to building patient-focused companies around transformative technologies, today announced it has entered into a partnership agreement with the Detroit-based Barbara Ann Karmanos Cancer Institute (Karmanos). This partnership between Hibiscus’ venture studio, Hibiscus BioTechnology, and Karmanos seeks to leverage the combined resources of the two organizations to develop innovative therapeutics for …
01/11/2022
Inorganic Ventures Expands With New Enterprise Development Team
Inorganic Ventures, a manufacturer of high-quality analytical inorganic standards for testing in a wide range of industries, today announced the addition of a new Enterprise Development division. Led by Justin Yalung, Chief Operating Officer, the company’s Enterprise Development arm will have overall authority for developing new products and expanding the organization’s portfolio. “The Enterprise Development division …
01/10/2022
New Patent for Caretaker Medical
Caretaker Medical has received issuance of a new Patent by the United States Patent and Trademark Office (USPTO) for self-calibrating systems for blood pressure wave form analysis and diagnostics, U.S. Patent No. 11,207,034, further strengthening the Company’s intellectual property position and coverage for the Company’s medical-grade continuous digital blood pressure and vital sign monitoring system. …
01/10/2022
Polycarbin Comes out of Stealth, Raising $2M from Ringbolt Capital and VoLo Earth Ventures to Decarbonize the Life Science and Healthcare Sector
SAN FRANCISCO–(BUSINESS WIRE)–Today, Polycarbin, Inc. announced the closing of a $2M seed round with funding from Ringbolt Capital, VoLo Earth Ventures, along with several notable angel investors to scale the only Closed-Loop solution for single-use plastics in the life science and healthcare sector. In the midst of a pandemic that has destabilized the supply chains …
01/07/2022
ATCC Announces Award from Leidos Biomedical Research for the Production and Distribution of Next-generation Cancer Models
ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a contract with Leidos Biomedical Research, Inc. (Leidos Biomed), current operator of the Frederick National Laboratory for Cancer Research, for the continued production, characterization and distribution of next-generation cancer models (NGCM). These models will be distributed solely by ATCC as …
01/06/2022
SanAir Technologies Laboratory Combines with Centek Laboratories
Expands Lab Testing Capabilities into Volatile Organic Compound (VOC) Air and Soil Gas Analysis RICHMOND, Va., SanAir Technologies Laboratory, Inc. (SanAir) today announced its merger with Syracuse, NY-based Centek Laboratories, LLC (Centek), expanding its testing capabilities into VOCs using summa cannister and/or thermal desorption tubes technology (EPA Method TO-15 and TO-17) and analyzation of samples by GC/MS coupled with …
01/04/2022
Fralin Biomedical Research Institute biotech spin-out raises additional $305,000 in investments
Acomhal Research Inc., a cancer research start-up founded by Fralin Biomedical Research Institute at VTC scientists, recently secured $305,000 in funding from the Virginia Tech Carilion Seed Fund, the Virginia Innovation Partnership Corporation, and angel investors. With a wave of new grants and investments, a cancer stem cell research company founded by Fralin Biomedical Research Institute …
12/15/2021
VT Corporate Research Center Receives GO Virginia Grant to Expand Lab Facilities and Resources
New collaboration with Johnson & Johnson Innovation announced with the aim to accelerate life science sector growth in the New River and Roanoke Valleys by providing access to expert mentors, programming, and commercialization resources for startup companies The GO Virginia Coalition today approved a grant award to the Virginia Tech Corporate Research Center (VTCRC) to fund the expansion …
12/14/2021
Bonumose’s Low-Cost Tagatose Process Receives Key Health Agency Approvals; Construction of First Production Facility on Schedule for Spring 2022 Opening
ASR Group – exclusive sales and distribution partner – reports strong customer demand for the unique, rare sugar, accelerating the timeline for a second production plant. Bonumose, Inc. announces the achievement of regulatory and food application milestones in the United States and Canada for the low-glycemic, rare sugar tagatose, as the company progresses on time …
12/14/2021
Prestigious annual pediatric medical device competition takes aim at congenital heart disease with five innovators sharing $150K in NCC-PDI grants
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announces five awardees chosen in its prestigious annual “Make Your Medical Device Pitch for Kids!” competition to share $150,000 in grant funding from the U.S. Food and Drug Administration (FDA) to support the advancement of pediatric medical devices. In an unprecedented decision, the competition judges determined that all …
12/14/2021
HemoShear Therapeutics Appoints Patrick Horn, MD, PhD, Chief Medical Officer
Industry Veteran Will Lead HST5040 and Future Rare Disease Clinical Programs HemoShear Therapeutics, Inc., a privately held biotechnology company developing drugs for rare metabolic disorders, has appointed Patrick Horn, MD, PhD, as Chief Medical Officer, effective January 1, 2022. Dr. Horn will lead the company’s growing clinical operations, clinical development, regulatory affairs, medical affairs, biometrics …
12/13/2021
Advanced Pharmaceutical Cluster Growth Project Chosen As Finalist In EDA’s Build Back Better Regional Challenge
The coalition will compete for up to $100 million to supercharge the economy of Central Virginia The coalition of public and private organizations in support of creating an advanced pharmaceutical cluster in Central Virginia was named by the Economic Development Administration (EDA) as a finalist in the $1 billion Build Back Better Regional Challenge. The …
12/13/2021
RIVANNA® Announces Partnership With BOMImed to Increase Distribution of Accuro® in Canada
RIVANNA®, developers of world-first, imaging-based medical solutions, announced they have entered into a partnership with BOMImed, a recognized manufacturer of anesthesia and critical care related consumables to represent and distribute the Accuro® portfolio of products in Canada. BOMImed is a choice distribution partner for RIVANNA as its focus is within the fields of anesthesia and critical …
12/10/2021
Virginia Catalyst Announces Round 13 of Grant Funding! Could you use $200,000 to $800,000 in a Non-Dilutive Grant?
The Virginia Catalyst, also known as the Virginia Biosciences Health Research Corporation (VBHRC), today announced that it is accepting letters of intent (LOI) for Grant Round 13 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “When you combine world class research with …
12/09/2021
Adial Announces Cary J. Claiborne has Joined the Company as Chief Operating Officer
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne as Chief Operating Officer. Mr. Claiborne will continue to serve on the Board of Directors. In his new role, Mr. Claiborne will be responsible for overseeing …
12/09/2021
Call to Action – NIH Technology Accelerator Challenge for Maternal Health – up to $1 Million in Cash Prizes!
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is proud to announce the launch of the NIH Technology Accelerator Challenge for Maternal Health (NTAC: Maternal Health) in conjunction with the White House Maternal Health Day of Action. NTAC: Maternal Health is offering up to $1,000,000 in cash prizes to reward the development of low-cost, point-of-care molecular, cellular, and/or metabolic sensing …
12/06/2021
Diffusion Pharmaceuticals Doses First Participants in Altitude Trial
Diffusion Pharmaceuticals Inc. (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced it has dosed the first participants in its Altitude Trial. The trial will evaluate the Company’s lead product candidate, trans sodium crocetinate (“TSC”), in normal …